-

Mednow to Host Quarterly Conference Call on Wednesday December 22, 2021, at 8:30am EST on its First-Quarter 2022 Financial Results and a Corporate Update

TORONTO--(BUSINESS WIRE)--Mednow Inc. (“Mednow'' or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Wednesday December 22, 2021 at 8:30am EST. The conference call will cover its first-quarter 2022 financial results, and an update.

During the call, the Mednow team will provide an update on Mednow’s national expansion, recent strategic partnerships, milestones, M&A activities, and first-quarter 2022 financial results. Please use one of the two dial-in numbers provided below five minutes before the scheduled start time and specify the Mednow call.

Conference Call details:

Canada/USA Toll-free: 1-800-319-4610

International Toll: 1-604-638-5340

The conference call will be available on our website at: https://investors.mednow.ca/financial-reports/ for playback within a few business days.

About Mednow Inc.

Mednow is a healthcare technology company offering virtual access with exceptional care. Designed with access and quality care in mind, Mednow.ca provides virtual pharmacy and telemedicine services, as well as doctor home visits, with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, and doctor consultations.

To learn more, follow Mednow on Facebook, Twitter, LinkedIn and Instagram, as well as visit www.mednow.ca/.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts

Investor Relations Contact:
Lucy Chitilian
ir@mednow.ca
647.933.6995

Industry:

Mednow Inc.

TSX VENTURE:mnow
Release Versions
English

Contacts

Investor Relations Contact:
Lucy Chitilian
ir@mednow.ca
647.933.6995

Social Media Profiles
mednowcanada
mednow.ca
Mednow.ca
mednowcanada
More News From Mednow Inc.

Mednow Restructuring to Meet Long-Term Needs of Stakeholders

VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today that it and certain of its subsidiaries, including thirteen of its Canadian operating subsidiaries, 2716725 Ontario Inc., 10111132 Manitoba Ltd. (dba Mednow MB), Mednow Clinic Services Inc., Mednow East Inc., Mednow Medical Inc., Mednow Ontario Limited, Mednow Pharmacy AB Ltd., Mednow Operations Inc., Mednow Pharmacy Inc., Mednow Pharmacy MB Ltd., Mednow Pharmacy Services Inc.,...

Mednow Announces Notice Received From Secured Creditor and Plan to Work on a Transitional Plan

VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company"), Canada’s on-demand virtual pharmacy, announced today that it has received a notice of default, demand and intention to enforce security from its related secured creditor Alirey Corp. amounting to $3.23 million. Mednow intends to cooperate with secured creditor to facilitate a transitional plan. About Mednow (TSXV: MNOW) (OTCQX: MDNWF) Mednow is a healthcare technology company offer...

Mednow Announces Corporate Update

VANCOUVER, British Columbia--(BUSINESS WIRE)--Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF) ("Mednow" or the "Company") announces that Ali Reyhany has stepped down as CEO, President and Director. Felipe Campusano has also resigned as a Director, Treasurer and Secretary. About Mednow (TSXV: MNOW) (OTCQX: MDNWF) Mednow is a healthcare technology company offering virtual access with a high-standard of care. Designed with accessibility and quality of care in mind, Mednow provides virtual pharmacy and tel...
Back to Newsroom